Significant differences in BM smears and MRD levels at TP1 and TP2 were not observed between patients with high and low CRLF2 expression, suggesting that CRLF2 overexpression was unrelated to the treatment response in pediatric T-ALL patients. The gene discussed is CRLF2; the disease is acute lymphoblastic leukemia.